APLT News and Press, Applied Therapeutics Inc. From 10/23/20

The stock market is undergoing some distribution. During these periods of time, stock selection is even more important. The POWR Ratings can help you identify ones that are performing well and avoid those with poor prospects. Here are five stocks the POWR Ratings have recently downgraded. ...

NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will p...

The FDA grants Pediatric Rare Disease and Orphan Designation to Applied Therapeutic's (APLT) +3.7% AT-007 for treatment of PMM2-CDG, a disease caused by deficiency in the critical enzyme phosphomannomutase-2, required for systemic glycosylation of proteins.AT-007, a novel ...

NEW YORK, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that the ...

NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will ...

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will ...

Gainers:  Comstock Mining (NYSEMKT: LODE ) +128% . More news on: Comstock Mining Inc., RISE Education Cayman Ltd, IMARA Inc., Stocks on the move, , Read more ...

Applied Therapeutics (NASDAQ: APLT ) discloses that the FDA placed a partial clinical hold on its ACTION-Kids Study on August 14 citing the need for additional technical information related to ensuring that every participant in the study has access to the drug's benefits. It says it will...

Applied Therapeutics (NASDAQ: APLT ) : Q2 GAAP EPS of -$1.27 misses by $0.56 . Cash and cash equivalents and short-term investments totaled $138.5M. Press Release More news on: Applied Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,

NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results fo...